Form 4: HealthStream Director Deborah Taylor Tate Reports Acquisition of Restricted Share Units

Director Deborah Taylor Tate reported the acquisition of 3,018 restricted share units (RSUs) in HealthStream Inc. (HSTM) on May 30, 2024.

Summary

• On May 30, 2024, Deborah Taylor Tate, a director of HealthStream Inc. (HSTM), acquired 3,018 restricted share units (RSUs).
• Each RSU represents the right to receive one share of HealthStream common stock upon vesting.
• The RSUs are subject to a three-year vesting schedule, with annual vesting beginning on May 30, 2025, in three equal installments, contingent upon continued service.
• Following the transaction, Ms. Tate directly owns 22,601 shares of HealthStream common stock and 3,018 RSUs.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by a director is generally seen as a positive sign, indicating confidence in the company's future. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs vest over a three-year period, aligning the director's interests with the long-term performance of the company.

Industry Context

Insider transactions are closely monitored as indicators of management's confidence in the company's prospects within the healthcare technology sector.

Comparison to Industry Standards

• RSU grants are a common form of executive compensation in the healthcare technology industry, used to incentivize long-term performance.
• Vesting schedules of three years are typical for RSU grants in comparable companies.

Stakeholder Impact

• The acquisition of RSUs by a director can positively influence shareholder sentiment.

Key Dates